Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Therapeutic lymphangiogenesis with human recombinant VEGF-C
(PMID 8669775)
Daily targets: Sodium: 2,000-2,500mg from food and supplementation Potassium: 4,000-4,700mg from food and conservative supplementation Magnesium glycinate: 300-400mg supplemental Calcium citrate: 600-1,000mg supplemental (divided doses) Vitamin D: 2,000 IU daily Implementation: Morning: magnesium glycinate (200mg) with food, electrolyte drink Midday: bone broth (400-500mg sodium), potassium-rich snack Afternoon: second electrolyte drink or salt tablet Evening: magnesium glycinate (200mg), calcium citrate (500mg), vitamin D Before bed: additional magnesium if experiencing cramps or insomnia This protocol is appropriate during dose escalation phases when side effects typically peak
Every step
To help preserve product quality: Keep refrigerated Protect from direct sunlight Do not freeze Keep sealed until required for laboratory use Follow standard laboratory handling procedures Proper storage supports compound integrity throughout the research period
US$ 24.74
US$ 26.23
US$ 28.35
